 BUFFALO, N.Y., May 02, 2022 GLOBE NEWSWIRE -- Athenex NASDAQ: ATNX, a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company will present at the upcoming ASGCT 25th Annual Meeting, taking place May 16-19, 2022, in Washington, D.C. The abstract associated with the presentation is now available on the conference website. 